Magic Hour
SoCal Gas
You are here:  Home  >  Central Coast Health Watch  >  Current Article

Amgen spends $10 billion to buy back 52.1 million shares

By   /   Tuesday, March 6th, 2018  /   Comments Off on Amgen spends $10 billion to buy back 52.1 million shares

    Print       Email
Amgen completed a $10 billion share buyback on March 5, rounding up around 52.1 million shares of its common stock for $192 apiece. The shares bought in the offer represent about 7.2 percent of total outstanding shares, the company said in a March 6 press release. The Thousand Oaks-based biotech giant announced its intent to…


    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email

You might also like...

Dole shares down after earnings drop

Read More →